Home/Filings/4/0000898432-20-000024
4//SEC Filing

McCreery John K 4

Accession 0000898432-20-000024

CIK 0001325618other

Filed

Jan 7, 7:00 PM ET

Accepted

Jan 8, 9:58 PM ET

Size

18.6 KB

Accession

0000898432-20-000024

Insider Transaction Report

Form 4
Period: 2020-01-06
McCreery John K
Chief Operating Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2020-01-06+1,08343,579 total
  • Exercise/Conversion

    Restricted Stock Units

    2020-01-0615,62515,625 total
    Common Stock (15,625 underlying)
  • Tax Payment

    Common Stock

    2020-01-06$25.06/sh180$4,51142,496 total
  • Exercise/Conversion

    Restricted Stock Units

    2020-01-061,0831,083 total
    Common Stock (1,083 underlying)
  • Exercise/Conversion

    Common Stock

    2020-01-06+73842,676 total
  • Tax Payment

    Common Stock

    2020-01-06$25.06/sh264$6,61643,315 total
  • Exercise/Conversion

    Common Stock

    2020-01-06+15,62546,012 total
  • Tax Payment

    Common Stock

    2020-01-06$25.06/sh4,074$102,09441,938 total
  • Exercise/Conversion

    Restricted Stock Units

    2020-01-06738738 total
    Common Stock (738 underlying)
Footnotes (6)
  • [F1]On April 27, 2017, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on April 27, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Vesting and settlement of the restricted stock units were accelerated to January 6, 2020.
  • [F2]Restricted stock units convert into common stock on a one-for-one basis.
  • [F3]Forfeiture of shares to satisfy tax obligations related to stock units for which vesting and settlement were accelerated to January 6, 2020. No shares were sold in connection with this transaction.
  • [F4]Vesting of restricted stock units granted to the reporting person on December 4, 2017 for which vesting and settlement were accelerated to January 6, 2020.
  • [F5]Vesting of restricted stock units granted to the reporting person on December 7, 2018 for which vesting and settlement were accelerated to January 6, 2020.
  • [F6]Vesting and settlement of the restricted stock units were accelerated to January 6, 2020.

Documents

1 file

Issuer

IRADIMED CORP

CIK 0001325618

Entity typeother

Related Parties

1
  • filerCIK 0001703458

Filing Metadata

Form type
4
Filed
Jan 7, 7:00 PM ET
Accepted
Jan 8, 9:58 PM ET
Size
18.6 KB